Virtual Trials vs Trial Virtualization


Virtual Trials vs Trial Virtualization

Prior to the pandemic only a handful of trials were using more than one virtualization solution. Now, the environment is inverting, and to move successfully into the next clinical paradigm we’re tasked with A) understanding the real-world effectiveness of these many rapidly deployed virtual initiatives, and B) further honing the patient and site experiences to drive better efficiencies and outcomes based on these insights.  

You must consider are we aiming to recreate trials in the virtual setting, or are we rethinking the way we approach trials from the perspective of what works best virtually? And how can we minimize the potential for added site burden through incorporating virtual solutions such as remote source data review into daily site operations. In our latest webinar we’ll be exploring the changing paradigm of study conduct to enable virtualization of clinical trials, both for patients and sites, and why it has become the industry’s new focus. 

In this session you will learn:  

  • Why you must define the “virtual clinical trial” around patient participation now to ensure long-term benefits to experience and outcomes 
  • How to streamline clinical timelines by implementing end-to-end virtualizing technologies to unify your platform approach 
  • The impact of virtualization technologies on sites and how to act now to ensure your ready to partner with changing future operating models 
  • How a combination of on-site and remote monitoring helps reduce risk, while increasing efficiency


Craig Lipset  Advisor and Founder, Clinical Innovation Partners


Anthony Costello  President, Patient Cloud, Medidata


Irfan Kahn  CEO of Circuit Clinical


Rosamund Round  VP Patient Innovation Center and Decentralized Trials, Parexel